Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · August 17, 2022

Thymosin α1 for Managing Radiation Pneumonitis in Patients With Locally Advanced NSCLC Treated With Concurrent Chemoradiotherapy

International Journal of Radiation Oncology, Biology, Physics


Additional Info

Disclosure statements are available on the authors' profiles:

International Journal of Radiation Oncology, Biology, Physics
Efficacy of thymosin α1 in management of radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy: A Phase 2 Clinical Trial (GASTO-1043)
Int. J. Radiat. Oncol. Biol. Phys 2022 Jul 20;[EPub Ahead of Print], F Liu, B Qiu, Y Xi, Y Luo, Q Luo, Y Wu, N Chen, R Zhou, J Guo, Q Wu, M Xiong, H Liu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading